BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments ...Middle East

PR Newswire - News
BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments
NEW YORK, Dec. 26, 2023 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today provided an update on the grant and allowance of three patent applications for NurOwn® and NurOwn-Exosomes....

Hence then, the article about brainstorm granted patents for allogeneic exosome platform product in neurological disorder treatments was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments )

Apple Storegoogle play

Last updated :

Also on site :



Latest News